Citations

Showing 10 of 108119 citations.

Clinical spectrum of neuropathy after primary total knee arthroplasty: A series of 54 cases
Speelziek, Scott J. A., Staff, Nathan P. , Laughlin, Ruple S. , Johnson, Rebecca L. , Staff, Nathan P , Sierra, Rafael J.

Mayo Clinic

Muscle & Nerve | March 21, 2019 | Volume: 59 | Issue: 6 | Pages: 679-682

10.1002/mus.26473 | PMID 30897216 Get It

ABSTRACTIntroductionNeuropathy after total knee arthroplasty (TKA) can cause significant morbidity but is inconsistently reported.MethodsWe reviewed the clinical, electrodiagnostic and perioperative features of all patients who underwent primary TKA at our institution and developed a new neuropathy within 8 weeks postoperatively.ResultsFifty‐four cases were identified (incidence 0.37% [95% confidence interval, 0.28–0.49]) affecting the following nerve(s): peroneal (37), sciatic (11), ulnar (2), tibial (2), sural (1), and lumbosacral plexus (1). In all cases with follow‐up data, motor recovery typically occurred within 1 year and was complete or near‐complete.ConclusionsPost‐TKA neuropathy is uncommon, typically does not require intervention and usually resolves within 1 year. Post‐TKA neuropathy most often affects the nerves surgically at risk. Anesthesia type does not correlate with post‐TKA neuropathy. An inflammatory etiology for post‐TKA neuropathy is rare but should be considered in specific cases. Muscle Nerve 59:679–682, 2019
Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas†
Hsu, Ying-Han R, Torres‐Mora, Jorge , Kipp, Benjamin R. , Sukov, William R. , Jenkins, Sarah M. , Voss, Jesse S. , Cassivi, Stephen D. , Roden, Anja C. , Barr Fritcher, Emily G, Hsu, Ying-Han R. , Fritcher, Emily G. Barr , Schaff, Hartzell V.

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | March 21, 2019 | Volume: 56 | Issue: 5 | Pages: 867-875

10.1093/ejcts/ezz115 | PMID 31329844 Get It

Abstract OBJECTIVES Paragangliomas have unique features in the mediastinum, in part due to their location. Because of their paucity, they have not been thoroughly investigated. We studied the clinical, pathological, immunohistochemical and molecular features of mediastinal paragangliomas. METHODS Immunohistochemistry, next-generation sequencing mutation panel and the Oncoscan assay were performed. RESULTS Twenty-four patients with mediastinal paraganglioma (7 men, 29.2%) had a median age of 45.5 years (19.8–72.2). Twenty-one (87.5%) paragangliomas were completely resected. Six (of 24, 25.0%) tumours were considered metastatic. Mitotic activity occurred in 11 (of 24, 45.8%) paragangliomas. Programmed death-ligand 1 (PD-L1) (n = 23) was expressed in 6 (26%) patients in 10% (n = 2) and 1% (n = 4) of tumour cells, respectively. SDHB expression was lost in 19 (of 22, 86.4%) cases. ATRX expression was lost in 11 (of 23, 47.8%) cases. Next-generation sequencing revealed a single pathogenic mutation in 10 (of 19) specimens including SDHB (n = 4), SDHD (n = 6), SDHC (n = 1), ATRX (n = 1), and ≥2 mutations in 2 cases [SDHC and TERT (n = 1); SDHB, ATRX and TP53 (n = 1)]. Germline mutation analysis revealed the same succinate dehydrogenase mutation (or lack thereof) as identified in the paraganglioma in 11 (of 12) cases. During a median follow-up (n = 21) of 4.8 years (0.8–14.9), 3 patients developed metastases; 4 patients died, at least 1 of disease. CONCLUSIONS Mediastinal paragangliomas can be associated with morbidity and mortality. Many mediastinal paragangliomas have been reported to be associated with syndromes such as multiple endocrine neoplasia, von Hippel-Lindau or succinate dehydrogenase syndrome with mutation profiles dominated by alterations in genes associated with these syndromes.
A Bayesian Approach to Multistate Hidden Markov Models: Application to Dementia Progression
Williams, Jonathan , Storlie, Curtis B. , Therneau, Terry M. , Jack, Clifford R. , Hannig, Jan , Jack, Clifford R , Williams, Jonathan P

Mayo Clinic

Journal of the American Statistical Association | March 21, 2019 | Volume: 115 | Issue: 529 | Pages: 16-31

10.1080/01621459.2019.1594831 Get It

Comparison of Outcomes Based on Graft Type and Tunnel Configuration for Primary Ulnar Collateral Ligament Reconstruction in Professional Baseball Pitchers
Griffith, Timothy B. , Gorroochurn, Prakash , D’Angelo, John , Altchek, David W. , Griffith, Timothy Bryan , Ahmad, Christopher S. , Ciccotti, Michael G. , Dines, Joshua S. , Camp, Christopher L.

Mayo Clinic

The American Journal of Sports Medicine | March 21, 2019 | Volume: 47 | Issue: 5 | Pages: 1103-1110

10.1177/0363546519831705 | PMID 30896975 Get It

Background: Professional baseball pitchers are at high risk for tears of the ulnar collateral ligament (UCL) of the elbow, often requiring surgical reconstruction. Despite acceptable published return-to-play outcomes, multiple techniques and graft types have been described. Purpose: This study compares UCL reconstruction (UCLR) outcomes based on tunnel configuration and graft type. Study Design: Cohort study; Level of evidence, 3. Methods: After approval from our institutional review board and Major League Baseball (MLB), 566 professional baseball pitchers who underwent UCLR between 2010 and 2014 were identified and included. The following patient characteristics were analyzed: age, pitching role (starter vs reliever), level of play (MLB vs Minor League Baseball [MiLB]), and throwing side dominance. Surgical factors analyzed included reconstruction technique, graft type, and concomitant procedures. Primary outcome measures consisted of the ability to return to play at any level (RTP), ability to return to the same level of play (RSL), time to return, subsequent elbow injuries, and need for subsequent or revision elbow surgery. The effects of patient and surgical factors on outcomes were analyzed using multivariate linear and logistic regression modeling. Results: The RTP rate was 79.9%, and the RSL rate was 71.2%. Grafts used to reconstruct the UCL included the palmaris longus autograft (n = 361, 63.7%), the gracilis autograft (n = 135, 23.8%), and other grafts (n = 70, 12.5%). Surgical techniques utilized were the docking technique (n = 171, 30.2%), the modified Jobe technique (n = 290, 51.2%), and other techniques (n = 105, 18.6%). There were no significant differences in the time to RTP or RSL based on reconstruction technique or graft type. RTP rates were similar for the docking versus modified Jobe technique (80.1% vs 82.4%, respectively; P = .537) and for the 2 primary graft types (83.1% for palmaris longus vs 80.7% for gracilis; P = .596). The rate of subsequent elbow surgery was 10.5% for the docking technique versus 14.8% for the modified Jobe technique ( P = .203), and the rate of revision UCLR was 2.9% versus 6.2% for the docking versus modified Jobe technique, respectively ( P = .128). Significant trends toward an increasing use of the palmaris longus autograft ( P = .023) and the docking technique ( P = .006) were observed. MLB pitchers were more likely than MiLB pitchers to RTP ( P < .001) and RSL ( P < .001), but they required a longer time to return (mean difference, 35 days; P = .039) and had a higher likelihood of subsequent elbow (odds ratio [OR], 3.58 [95% CI, 2.06-6.23]; P < .001) and forearm injuries (OR, 5.70 [95% CI, 1.99-16.30]; P = .004) but not subsequent elbow surgery. No specific variables correlated with the rates of subsequent elbow surgery or revision UCLR in the multivariate analysis. The use of concomitant ulnar nerve transposition did not affect outcomes. Conclusion: Surgical outcomes in professional baseball players are not significantly influenced by UCLR technique or graft type. There was a high rate (46.3%) of subsequent throwing elbow injuries. MLB pitchers were more likely to RTP and RSL, but they had a higher frequency of subsequent elbow and forearm injuries than MiLB pitchers. Both the docking technique and the palmaris longus autograft are increasing in popularity among surgeons treating professional baseball players.
Preferential Disruption of Auditory Word Representations in Primary Progressive Aphasia With the Neuropathology of FTLD-TDP Type A
Mesulam, Marek-Marsel, Nelson, Matthew J. , Hyun, JungMoon , Rader, Benjamin , Hurley, Robert S. , Rademakers, Rosa , Bigio, Eileen H. , Weıntraub, Sandra , Baker, Matthew C, Mesulam, Marek-Marsel, Baker, Matthew

Mayo Clinic

Cognitive and Behavioral Neurology | March 21, 2019 | Volume: 32 | Issue: 1 | Pages: 46-53

10.1097/wnn.0000000000000180 | PMID 30896577 Get It

Four patients with primary progressive aphasia displayed a greater deficit in understanding words they heard than words they read, and a further deficiency in naming objects orally rather than in writing. All four had frontotemporal lobar degeneration-transactive response DNA binding protein Type A neuropathology, three determined postmortem and one surmised on the basis of granulin gene (GRN) mutation. These features of language impairment are not characteristic of any currently recognized primary progressive aphasia variant. They can be operationalized as manifestations of dysfunction centered on a putative auditory word-form area located in the superior temporal gyrus of the left hemisphere. The small size of our sample makes the conclusions related to underlying pathology and auditory word-form area dysfunction tentative. Nonetheless, a deeper assessment of such patients may clarify the nature of pathways that link modality-specific word-form information to the associations that mediate their recognition as concepts. From a practical point of view, the identification of these features in patients with primary progressive aphasia should help in the design of therapeutic interventions where written communication modalities are promoted to circumvent some of the oral communication deficits.
Critical Care Ultrasound Should Not Be a Priority First-Line Assessment Tool in the Management of Neurocritically Ill Patients
Prada, Gabriel , Vespa, Paul

Mayo Clinic

Critical Care Medicine | March 21, 2019 | Volume: 47 | Issue: 6 | Pages: 837-839

10.1097/ccm.0000000000003736 | PMID 30889021 Get It

Faculty Opinions recommendation of Maturation of the respiratory complex II flavoprotein.
Maher, Jim

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735291765.793557747 Get It

Review of Ilana Löwy, Imperfect Pregnancies: A History of Birth Defects & Prenatal Diagnosis
Riggan, Kirsten A. , Riggan, Kirsten A

Mayo Clinic

The American Journal of Bioethics | March 21, 2019 | Volume: 19 | Issue: 3 | Pages: W1-W3

10.1080/15265161.2018.1563648 Get It

Cushing syndrome: uncovering Carney complex due to novel PRKAR1A mutation
Zhang, Catherine D , Pichurin, Pavel N. , Bobr, Aleh , Lyden, Melanie L. , Young, William F. , Bancos, Irina

Mayo Clinic

Endocrinology, Diabetes & Metabolism Case Reports | March 21, 2019 | Volume: 2019 | Issue: No issue available | Pages: No page available

10.1530/edm-18-0150 | PMID 30897549 Get It

Summary Carney complex (CNC) is a rare multiple neoplasia syndrome characterized by spotty pigmentation of the skin and mucosa in association with various non-endocrine and endocrine tumors, including primary pigmented nodular adrenocortical disease (PPNAD). A 20-year-old woman was referred for suspected Cushing syndrome. She had signs of cortisol excess as well as skin lentigines on physical examination. Biochemical investigation was suggestive of corticotropin (ACTH)-independent Cushing syndrome. Unenhanced computed tomography scan of the abdomen did not reveal an obvious adrenal mass. She subsequently underwent bilateral laparoscopic adrenalectomy, and histopathology was consistent with PPNAD. Genetic testing revealed a novel frameshift pathogenic variant c.488delC/p.Thr163MetfsX2 (ClinVar Variation ID: 424516) in the PRKAR1A gene, consistent with clinical suspicion for CNC. Evaluation for other clinical features of the complex was unrevealing. We present a case of PPNAD-associated Cushing syndrome leading to the diagnosis of CNC due to a novel PRKAR1A pathogenic variant. Learning points: PPNAD should be considered in the differential for ACTH-independent Cushing syndrome, especially when adrenal imaging appears normal. The diagnosis of PPNAD should prompt screening for CNC. CNC is a rare multiple neoplasia syndrome caused by inactivating pathogenic variants in the PRKAR1A gene. Timely diagnosis of CNC and careful surveillance can help prevent potentially fatal complications of the disease.
IgG4-Related Disease Presenting as Chest Wall Mass
Vasireddy, Amit, Ernste, Floranne C. , Baqir, Misbah , Yi, Eunhee S. , Ryu, Jay H. , Ryu, Jay H

Mayo Clinic

JCR: Journal of Clinical Rheumatology | March 21, 2019 | Volume: 26 | Issue: 5 | Pages: e108-e109

10.1097/rhu.0000000000000975 | PMID 30585990 Get It